SCM1R Siguldas Ciltslietu un Maksligas Apseklosanas Stacija

Siguldas CMAS JSC Audited Annual Report for 2019

Siguldas CMAS JSC Audited Annual Report for 2019

The Company’s net turnover in 2019 was 1.2 million euros, which is by 62 thousand euros or 5.5% bigger than in 2018.

The proportion of the revenue from the Company’s basic economic activities, if compared to year 2018, had not changed substantially − the revenue from the sales of the bull semen comprised 54.8% of the net turnover, whereas the milk laboratory services and processing of supervisory data services, taken together, accounted for 36.0% of the net turnover.

2019 ended with a profit of 50 thousand euros. Compared to 2018, profit before taxes for the reporting year has increased by 61 thousand euros, mainly due to the increase in net turnover.

The outbreak of COVID-19 will not have a substantial impact on the Company's operations, financial situation and economic performance.

PROFIT OR LOSS ACCOUNT

 2019

EUR
2018

EUR
Net sales:1 188 5271 126 778
a) from agricultural activities1 188 5271 126 778
Changes in stock or ready-made goods and unfinished products10 21917 874
Other operating income36 03622 992
Costs of materials:(531 271)(511 496)
a) raw materials and auxiliary costs of materials(424 415)(408 943)
b) other external costs(106 856)(102 553)
Personnel costs:(465 076)(487 067)
a) salaries for work(366 701)(385 412)
b) state social insurance compulsory contributions(86 480)(91 481)
c) other social insurance costs(11 895)(10 174)
Depreciation adjustments:(101 982)(85 987)
a) depreciation adjustments of fixed and intangible assets(51 252)(52 784)
b) depreciation adjustments of current assets which the company considers to be above the normal write-off amounts(50 730)(33 203)
Other operating costs(86 110)(93 913)
Profit or loss before enterprise income tax50 343(10 819)
Enterprise income tax for the reporting year--
Profit or loss after enterprise income tax calculation50 343(10 819)
The profit or loss for the year 50 343 (10 819)
Equity per 1 share (EPS)0.119(0.026)

JSC ‘Siguldas ciltslietu un mākslīgās apsēklošanas stacija’ is one of the largest high-quality breeding bull semen producers and suppliers in Latvia. The second largest field of the Company’s basic economic activities is milk testing services. The Company also provides other breeding related services – consultations on issues of cattle breeding, feeding and keeping, evaluation of cow exterior, artificial insemination of cows, initial processing of the monitoring data.

Valda Mālniece

Member of the Management Board, Manager of the Financial and Accounting department

E-mail:

Attachments

EN
23/03/2020

Underlying

Reports on Siguldas Ciltslietu un Maksligas Apseklosanas Stacija

 PRESS RELEASE

JSC ‘Siguldas ciltslietu un mākslīgās apsēklošanas stacija’ unaudited ...

JSC ‘Siguldas ciltslietu un mākslīgās apsēklošanas stacija’ unaudited financial information for the first three months of the year 2025 In the first three months of 2025, the net turnover was 469.4 thousand. euros, which is 24.1% more than in the first three months of the previous year, whereas profit before taxes was 34.8 thousand. euros – by 5.1 thousand. euros more compared to the corresponding period in 2024. JSC ‘Siguldas ciltslietu un mākslīgās apsēklošanas stacija’ is the only producer of high-quality breeding bull semen and one of the largest suppliers of it in Latvia. Th...

 PRESS RELEASE

AS “Siguldas ciltslietu un mākslīgās apsēklošanas stacija” nerevidēta ...

AS “Siguldas ciltslietu un mākslīgās apsēklošanas stacija” nerevidēta finanšu informācija par pirmajiem trim 2025. gada mēnešiem 2025. gada pirmajos trīs mēnešos neto apgrozījums bija 469,4 tūkst. eiro, kas ir par 24,1% vairāk nekā iepriekšējā gada pirmajos trīs mēnešos, bet peļņa pirms nodokļiem bija 34,8 tūkst. eiro – par 5,1 tūkst. eiro lielāka, salīdzinot ar iepriekšējā gada attiecīgo periodu. AS „Siguldas ciltslietu un mākslīgās apsēklošanas stacija” ir vienīgais augstvērtīgas vaislas buļļu spermas ražotājs un viens no lielākajiem tās piegādātājiem Latvijā. Otra lielākā Sabi...

 PRESS RELEASE

JSC ‘Siguldas ciltslietu un mākslīgās apsēklošanas stacija’ resolution...

JSC ‘Siguldas ciltslietu un mākslīgās apsēklošanas stacija’ resolutions to the Annual Shareholders’ Meeting on 25 April 2025 To approve the reports of the company’s management board and the supervisory board on the annual report for the year 2024.To approve the annual report for the year 2024, including the corporate governance report and the remuneration report for members of the management board and the supervisory board, prepared as separate components of the annual report.To leave the profit of the reporting year 80 788.23 euro undistributed. To discharge the members of the management b...

 PRESS RELEASE

AS “Siguldas ciltslietu un mākslīgās apsēklošanas stacija” kārtējās ak...

AS “Siguldas ciltslietu un mākslīgās apsēklošanas stacija” kārtējās akcionāru sapulces 2025. gada 25. aprīlī lēmumi Apstiprināt akciju sabiedrības valdes un padomes ziņojumus par 2024. gada pārskatu.Apstiprināt gada pārskatu par 2024. gadu, t. sk. korporatīvās pārvaldības ziņojumu un valdes un padomes atalgojuma ziņojumu, kas sagatavoti kā atsevišķas gada pārskata sastāvdaļas.Pārskata gada peļņu 80 788,23 EUR atstāt nesadalītu. Atbrīvot valdes un padomes locekļus, kā arī revidentu no atbildības par darbību 2024. gadā un atteikties no prasību celšanas pret viņiem.Par sabiedrības revidentu ie...

 PRESS RELEASE

JSC ‘Siguldas ciltslietu un mākslīgās apsēklošanas stacija’ Draft Reso...

JSC ‘Siguldas ciltslietu un mākslīgās apsēklošanas stacija’ Draft Resolutions to the Regular Shareholders’ Meeting on 25 April 2025 1. To approve the reports of the company’s management board and the supervisory board on the annual report for the year 2024. 2. To approve the annual report for the year 2024, including the corporate governance report and the remuneration report for members of the management board and the supervisory board, prepared as separate components of the annual report. 3. To leave the profit of the reporting year 80 788.23 euro undistributed.  4. To discharge the me...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch